These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924 [TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype. Sebastián E; Alcoceba M; Balanzategui A; Marín L; Montes-Moreno S; Flores T; González D; Sarasquete ME; Chillón MC; Puig N; Corral R; Pardal E; Martín A; González-Barca E; Caballero MD; San Miguel JF; García-Sanz R; González M Am J Pathol; 2012 Nov; 181(5):1879-88. PubMed ID: 22982190 [TBL] [Abstract][Full Text] [Related]
12. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors. Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849 [TBL] [Abstract][Full Text] [Related]
13. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia. Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012 [TBL] [Abstract][Full Text] [Related]
14. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100 [TBL] [Abstract][Full Text] [Related]
15. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia]. Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175 [TBL] [Abstract][Full Text] [Related]
16. IGHV unmutated status influences outcome more than IGHV1-69 gene usage per se in patients with chronic lymphocytic leukemia. Orlandi EM; Zibellini S; Pascutto C; Picone C; Giardini I; Pochintesta L; Lazzarino M Clin Lymphoma Myeloma; 2009 Oct; 9(5):390-3. PubMed ID: 19858060 [TBL] [Abstract][Full Text] [Related]
17. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Kostareli E; Hadzidimitriou A; Stavroyianni N; Darzentas N; Athanasiadou A; Gounari M; Bikos V; Agathagelidis A; Touloumenidou T; Zorbas I; Kouvatsi A; Laoutaris N; Fassas A; Anagnostopoulos A; Belessi C; Stamatopoulos K Leukemia; 2009 May; 23(5):919-24. PubMed ID: 19148139 [TBL] [Abstract][Full Text] [Related]
18. IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group. Kryachok I; Abramenko I; Bilous N; Chumak A; Martina Z; Filonenko I Med Oncol; 2012 Jun; 29(2):1093-101. PubMed ID: 21503826 [TBL] [Abstract][Full Text] [Related]
19. High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival. Kotaskova J; Tichy B; Trbusek M; Francova HS; Kabathova J; Malcikova J; Doubek M; Brychtova Y; Mayer J; Pospisilova S J Mol Diagn; 2010 May; 12(3):328-34. PubMed ID: 20228263 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia. Rani L; Mathur N; Gogia A; Vishnubhatla S; Kumar L; Sharma A; Dube D; Kaur P; Gupta R Leuk Lymphoma; 2016 Oct; 57(10):2389-400. PubMed ID: 26942309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]